Average Co-Inventor Count = 10.70
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Nimbus Saturn, Inc. (10 from 10 patents)
2. Chdi Foundation, Inc. (8 from 53 patents)
3. Calliditas Therapeutics Suisse Sa (1 from 2 patents)
19 patents:
1. 12466841 - Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists
2. 12252488 - HPK1 antagonists and uses thereof
3. 12215105 - HPK1 antagonists and uses thereof
4. 12202816 - Compounds as NADPH oxidase inhibitors
5. 12071442 - Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists
6. 11926625 - HPK1 antagonists and uses thereof
7. 11685734 - ATM kinase inhibitors and compositions and methods of use thereof
8. 11548890 - HPK1 antagonists and uses thereof
9. 11078201 - Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonists
10. 11034694 - Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists
11. 11028085 - Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonists
12. 11021481 - Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists
13. 10457675 - Histone deacetylase inhibitors and compositions and methods of use thereof
14. 10106535 - Histone deacetylase inhibitors and compositions and methods of use thereof
15. 10065948 - Histone deacetylase inhibitors and compositions and methods of use thereof